This study aimed to examine the levels of 25 hydroxy vitamin D (25-OH D) in preeclampsia and normotensive pregnant groups. A total of 70 pregnant women who came to the Health Sciences University, Istanbul Gaziosmanpasa Training and Research Hospital for delivery at 35-40 weeks of gestation were included in the study. The study group consisted of 35 preeclamptic (n=35) and 35 normotensive (n=35) pregnant women. Demographic, obstetric, and laboratory results of the two groups were compared in terms of 25-OH D levels. There was no statistically significant difference with the control group in terms of maternal age, gestational age at birth, gravidity, parity, number of abortions and living children, and BMI (p>0.05). When the mean diastolic blood pressure and systolic blood pressure of the groups were compared, the mean blood pressure of the individuals in the preeclamptic group was found to be statistically and significantly higher than the mean systolic and diastolic blood pressure of the individuals in the control group (p<0.05). When the groups were compared in terms of LFT (ALT, AST), proteinuria in urine, and platelet levels in blood, no statistically significant difference was found between the groups. Vitamin D levels were found to be statistically significantly lower in preeclamptic pregnancies compared to normotensive pregnancies. Low maternal vitamin D levels may play a role in the etiology of essential hypertension and preeclampsia, and more comprehensive research is needed on the potential positive effects of additional vitamin D supplementation.
Objective: To evaluate fetal pulmonary artery hemodynamics (PAAT, PAET, PATET) in pregnancies complicated by intrahepatic cholestasis of pregnancy (ICP) and to investigate their association with the aspartate aminotransferase-to-platelet ratio index (APRI). Methods: In this prospective study, 64 ICP cases and 64 healthy pregnancies are included. Doppler measurements of the fetal main pulmonary artery, umbilical artery (UAPI), and middle cerebral artery (MCAPI) were performed by a single operator, and all biochemical analyses were conducted in the same laboratory. APRI was calculated using the standard formula. Results: Doppler evaluation demonstrated significantly higher PAAT, PAET, PATET, UAPI, and MCAPI values in the ICP group (all p < 0.05). AST, ALT, and APRI levels were markedly elevated in ICP pregnancies (all p < 0.001). No significant correlation was observed between PATET and APRI (p = 0.368) or fasting bile acid levels (FBA) (p = 0.116), whereas APRI showed a weak positive correlation with FBA (r = 0.308; p = 0.013). Doppler parameters and APRI values did not differ significantly according to cholestasis severity (10–39/≥40/≥100 μmol/L; all p > 0.05). Conclusions: In ICP, fetal pulmonary artery Doppler indices (PAAT, PAET, PATET) and fetoplacental Doppler parameters are increased; the elevation in PATET is consistent with lower—rather than higher—fetal pulmonary vascular resistance, potentially reflecting accelerated fetal lung maturation or a hemodynamic adaptation to ICP-related physiological perturbations. Despite elevated APRI levels, these biochemical changes do not parallel fetal hemodynamic indicators. These findings suggest that fetal hemodynamic effects in ICP may be independent of biochemical disease severity. PATET is best conceptualized as a hemodynamic monitoring variable complementing bile acid assessment in fetal surveillance, not as a standalone screening or prognostic tool.
Background/Objectives: To identify the clinical factors associated with a multidisciplinary fetal council’s recommendation for termination of pregnancy in fetuses with renal anomalies, to describe how often families followed this recommendation, and to describe outcomes among continued pregnancies. Methods: This retrospective cohort study included 103 singleton pregnancies with a prenatally diagnosed renal or urinary tract anomaly discussed at a tertiary fetal council between December 2023 and July 2026. Renal severity, gestational age at diagnosis, amniotic fluid status, associated fetal abnormalities, and genetic evaluation were examined in relation to the council recommendation. Independent associations were assessed using multivariable logistic regression, Poisson regression with robust variance estimation, and Firth penalized logistic regression. Postnatal outcomes were summarized for pregnancies that continued. Results: A termination recommendation was issued in 59 of 103 pregnancies (57.3%). Of these, 43 families (72.9%) accepted it and the pregnancy was terminated, whereas 16 (27.1%) continued the pregnancy. Later diagnosis and moderate or low renal severity were independently associated with a lower likelihood of a termination recommendation. The presence of an additional fetal anomaly (adjusted odds ratio [aOR] 8.24, 95% confidence interval [CI] 1.59–42.65) and completion of genetic testing (aOR 4.53, 95% CI 1.45–14.15) were independently associated with a higher likelihood of such a recommendation. Among 60 continued pregnancies, 11 intrauterine or neonatal/postnatal deaths occurred (18.3%); mortality was 42.9% in the high-severity group and 5.3% in the low-severity group. The prenatal renal finding was confirmed postnatally in 22 cases, while renal-specific follow-up was unavailable in 18. Conclusions: Termination recommendations issued after prenatal detection of a renal anomaly were shaped by the timing of diagnosis, expected renal prognosis, the wider fetal phenotype, and the availability of genetic information. The observed difference between the council recommendation and the parental decision, together with substantial variation in postnatal outcomes, supports individualized counseling within a multidisciplinary framework.
30 June 2025 in Cukurova Anestezi ve Cerrahi Bilimler Dergisi
Objective: To assess the concordance between preoperative endometrial biopsy and final postoperative histopathological findings in patients with endometrioid-type endometrial cancer, and to identify factors associated with diagnostic discrepancies. Materials and Methods: This retrospective study included 134 patients who underwent surgery between 2005 and 2018 following a preoperative diagnosis of endometrioid-type endometrial cancer at a tertiary center. Demographic, clinical, and histopathological data were reviewed. Concordance between preoperative biopsy and final pathology was evaluated using Cohen’s kappa coefficient. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were also calculated. Results: A statistically significant correlation was observed between preoperative and final tumor grades (p < 0.001). In 35.8% of patients (n = 48), the final pathology revealed a higher grade than the initial biopsy. Grade 3 tumors demonstrated the highest diagnostic accuracy (89.5%), while Grades 1 and 2 showed an overall accuracy of 66.0%. Tumor size greater than 2 cm and lymph node metastasis were significantly associated with grade upgrading (p = 0.014 and p = 0.004, respectively). Conclusion: Preoperative biopsy alone may not be sufficient for accurate risk stratification in patients with endometrial cancer. Tumor upgrading was significantly associated with adverse prognostic indicators such as larger tumor size and nodal involvement. A multimodal diagnostic approach is recommended, particularly in cases initially classified as low-grade.
Background/Objectives: Termination of pregnancy (TOP) following a prenatal diagnosis of congenital heart disease (CHD) is a complex decision shaped by clinical, ethical, and psychosocial factors. This study evaluated the clinical factors associated with parental acceptance of TOP after prenatal diagnosis of CHD in a multidisciplinary counselling setting. Methods: This retrospective cohort study was conducted at a tertiary referral center where fetal CHD cases are evaluated in a multidisciplinary perinatology council. Pregnancies with a prenatal CHD diagnosis for which TOP was medically recommended between December 2023 and February 2026 were included. Maternal, fetal, and genetic data were analyzed. Cardiac severity was classified using the fetal cardiovascular disease severity scale. Because the cohort included only 62 pregnancies, a simplified multivariable logistic regression model with three clinically prespecified variables (four parameters: gestational age, cardiac severity, and genetic-evaluation status) was used to identify variables associated with termination acceptance. Results: Sixty-two pregnancies were included; 41 (66.1%) accepted termination and 21 (33.9%) continued the pregnancy. Maternal characteristics and gestational age at diagnosis were similar between groups. In the multivariable model, genetic-evaluation status was the only variable independently associated with termination acceptance. Compared with cases without genetic testing, both major chromosomal/pathogenic anomalies (aOR 4.97; 95% CI 1.29–19.11; p = 0.020) and a normal genetic-evaluation status (aOR 4.71; 95% CI 1.07–20.77; p = 0.041) were associated with higher termination acceptance. Cardiac severity and gestational age were not independently associated with parental decision. Conclusions: Genetic-evaluation status was associated with parental acceptance of termination after prenatal CHD diagnosis in a multidisciplinary counselling setting; given the small sample size and the selected, council-recommended cohort studied, this association should be interpreted as hypothesis-generating rather than as evidence of a causal or independent predictive effect.